These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26888765)

  • 1. Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine.
    Vistisen D; Andersen GS; Hansen CS; Hulman A; Henriksen JE; Bech-Nielsen H; Jørgensen ME
    Circulation; 2016 Mar; 133(11):1058-66. PubMed ID: 26888765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes.
    Vistisen D; Andersen GS; Hulman A; McGurnaghan SJ; Colhoun HM; Henriksen JE; Thomsen RW; Persson F; Rossing P; Jørgensen ME
    Diabetes Care; 2021 Apr; 44(4):901-907. PubMed ID: 33509931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prediction of Atherosclerotic Cardiovascular Disease in Type 1 Diabetes Mellitus: Do We Just Stop Here?
    Eckel RH; Hokanson JE
    Circulation; 2016 Mar; 133(11):1051-3. PubMed ID: 26888766
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and Validation of the American Heart Association's PREVENT Equations.
    Khan SS; Matsushita K; Sang Y; Ballew SH; Grams ME; Surapaneni A; Blaha MJ; Carson AP; Chang AR; Ciemins E; Go AS; Gutierrez OM; Hwang SJ; Jassal SK; Kovesdy CP; Lloyd-Jones DM; Shlipak MG; Palaniappan LP; Sperling L; Virani SS; Tuttle K; Neeland IJ; Chow SL; Rangaswami J; Pencina MJ; Ndumele CE; Coresh J;
    Circulation; 2024 Feb; 149(6):430-449. PubMed ID: 37947085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Rawshani A; Rawshani A; Sattar N; Franzén S; McGuire DK; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; Rosengren A; Gudbjörnsdottir S
    Circulation; 2019 Apr; 139(16):1900-1912. PubMed ID: 30798638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.
    Zareini B; Blanche P; D'Souza M; Elmegaard Malik M; Nørgaard CH; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006260. PubMed ID: 32571092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study.
    Koo BK; Chung WY; Moon MK
    Cardiovasc Diabetol; 2020 Jun; 19(1):82. PubMed ID: 32534580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated hemoglobin measurement and prediction of cardiovascular disease.
    ; Di Angelantonio E; Gao P; Khan H; Butterworth AS; Wormser D; Kaptoge S; Kondapally Seshasai SR; Thompson A; Sarwar N; Willeit P; Ridker PM; Barr EL; Khaw KT; Psaty BM; Brenner H; Balkau B; Dekker JM; Lawlor DA; Daimon M; Willeit J; Njølstad I; Nissinen A; Brunner EJ; Kuller LH; Price JF; Sundström J; Knuiman MW; Feskens EJ; Verschuren WM; Wald N; Bakker SJ; Whincup PH; Ford I; Goldbourt U; Gómez-de-la-Cámara A; Gallacher J; Simons LA; Rosengren A; Sutherland SE; Björkelund C; Blazer DG; Wassertheil-Smoller S; Onat A; Marín Ibañez A; Casiglia E; Jukema JW; Simpson LM; Giampaoli S; Nordestgaard BG; Selmer R; Wennberg P; Kauhanen J; Salonen JT; Dankner R; Barrett-Connor E; Kavousi M; Gudnason V; Evans D; Wallace RB; Cushman M; D'Agostino RB; Umans JG; Kiyohara Y; Nakagawa H; Sato S; Gillum RF; Folsom AR; van der Schouw YT; Moons KG; Griffin SJ; Sattar N; Wareham NJ; Selvin E; Thompson SG; Danesh J
    JAMA; 2014 Mar; 311(12):1225-33. PubMed ID: 24668104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus.
    Yang X; So WY; Kong AP; Ma RC; Ko GT; Ho CS; Lam CW; Cockram CS; Chan JC; Tong PC
    Am J Cardiol; 2008 Mar; 101(5):596-601. PubMed ID: 18308005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial dysfunction, neuropathy and nephropathy in long standing type 1 diabetic patients].
    Galicka-Latała D; Konduracka E; Kuźniewski M; Fedak D; Sieradzki J
    Przegl Lek; 2005; 62(12):1451-4. PubMed ID: 16786771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a cardiovascular risk prediction model in type 1 diabetes.
    McGurnaghan SJ; McKeigue PM; Read SH; Franzen S; Svensson AM; Colombo M; Livingstone S; Farran B; Caparrotta TM; Blackbourn LAK; Mellor J; Thoma I; Sattar N; Wild SH; Gudbjörnsdottir S; Colhoun HM;
    Diabetologia; 2021 Sep; 64(9):2001-2011. PubMed ID: 34106282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.